Related Experiment Video
Updated: Jul 20, 2026

07:13
An Alternative and Validated Injection Method for Accessing the Subretinal Space via a Transcleral Posterior Approach
Published on: December 7, 2016
13.9K
Central Retinal Artery Occlusion After Intravitreal Injection of Faricimab: A Case Report
Hiromasa Hirai1, Shinnosuke Yasuda1, Sho Imoto1
1Ophthalmology, Nara Medical University, Kashihara, JPN.
Cureus
|September 29, 2025
Summary
Central retinal artery occlusion (CRAO) is a rare adverse event following faricimab injections. This case highlights the potential vascular complication, urging ophthalmologists to inform patients about this risk.
Area of Science:
- Ophthalmology
- Vascular Biology
- Pharmacology
Background:
- Faricimab is a novel bispecific antibody targeting VEGF-A and angiopoietin-2.
- While effective for retinal diseases, rare adverse events like retinal vasculitis have been noted.

